Literature DB >> 8446263

Plasma parameters of the prothrombotic state in chronic uremia.

A Sagripanti1, A Cupisti, U Baicchi, M Ferdeghini, E Morelli, G Barsotti.   

Abstract

We measured plasma parameters of the prothrombotic state, namely thrombin-antithrombin III complex (TAT), fibrinopeptide A (FPA). D-dimer (DD), von Willebrand factor (vWF), tissue-type plasminogen activator (tPA), beta-thromboglobulin (beta TG), platelet factor 4 (PF4) and serotonin (5HT) in a series of 51 adult patients with chronic uremia: 22 were on maintenance hemodialysis (MHD) and 29 on conservative dietary treatment. Serum tumor necrosis factor alpha (TNF) was determined as well. Uremics presented significantly higher levels of TAT, FPA, DD, vWF, TNF, beta TG and 5HT than normal controls. Patients on conservative treatment showed lower levels of TAT, DD, TNF and beta TG than patients on MHD. Our results provide evidence that a prothrombotic state exists in chronic uremia and that MHD patients have a higher degree of hypercoagulation. Both hemodialysis procedure and uremia-related factors are likely to contribute to the hemostatic derangement.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8446263     DOI: 10.1159/000187209

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  9 in total

1.  Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention.

Authors:  Patrik Htun; Suzanne Fateh-Moghadam; Christian Bischofs; Winston Banya; Karin Müller; Boris Bigalke; Konstantinos Stellos; Andreas E May; Marcus Flather; Meinrad Gawaz; Tobias Geisler
Journal:  J Am Soc Nephrol       Date:  2011-01-27       Impact factor: 10.121

Review 2.  Antiplatelet agents in hemodialysis.

Authors:  Massimiliano Migliori; Vincenzo Cantaluppi; Alessia Scatena; Vincenzo Panichi
Journal:  J Nephrol       Date:  2016-12-08       Impact factor: 3.902

3.  Protein Z levels in haemodialysis patients.

Authors:  C Usalan; Y Erdem; B Altun; M Arici; I C Haznedaroğlu; U Yasavul; C Turgan; S Cağlar
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

4.  Coagulation factors as biological risk markers of endothelial dysfunction. Association with the thrombotic episodes of chronic hemodialysis patients.

Authors:  A Sioulis; P Malindretos; A Makedou; P Makris; D Grekas
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

5.  Pulmonary embolism in patients with CKD and ESRD.

Authors:  Gagan Kumar; Ankit Sakhuja; Amit Taneja; Tilottama Majumdar; Jayshil Patel; Jeff Whittle; Rahul Nanchal
Journal:  Clin J Am Soc Nephrol       Date:  2012-07-26       Impact factor: 8.237

6.  Patients with chronic kidney disease/diabetes mellitus: the high-risk profile in acute coronary syndrome.

Authors:  Usman Baber; Uschi Auguste
Journal:  Curr Cardiol Rep       Date:  2013-08       Impact factor: 2.931

7.  Recurrent white thrombi formation in hemodialysis tubing: a case report.

Authors:  Kiran P Sathe; Wee-Song Yeo; Isaac Desheng Liu; Sudha Ekambaram; Mohammed Azar; Hui-Kim Yap; Kar-Hui Ng
Journal:  BMC Nephrol       Date:  2015-01-15       Impact factor: 2.388

8.  Oxidized plasma albumin promotes platelet-endothelial crosstalk and endothelial tissue factor expression.

Authors:  Lisa Pasterk; Sandra Lemesch; Bettina Leber; Markus Trieb; Sanja Curcic; Vanessa Stadlbauer; Rufina Schuligoi; Rudolf Schicho; Akos Heinemann; Gunther Marsche
Journal:  Sci Rep       Date:  2016-02-24       Impact factor: 4.379

9.  Pulmonary embolism in chronic kidney disease and end-stage renal disease hospitalizations: Trends, outcomes, and predictors of mortality in the United States.

Authors:  Jagmeet Singh; Sushmita Khadka; Dhanshree Solanki; Asim Kichloo; Harshil Shah; Manasee J Vyas; Savneek Chugh; Neil Patel; Shantanu Solanki
Journal:  SAGE Open Med       Date:  2021-06-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.